This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event from December 12 - 16, 2021
Live In-Person Experience Delivered December 12 - 16 2021Marriott Marquis San Diego

John "Lippy" Lippincott, PhD
Vice President of Research at AlivaMab Discovery Services


Lippy is Vice President of Research at AlivaMab Discovery Services. He has over two decades of experience in the generation and characterization of antibodies from in vivo systems. Prior to joining AlivaMab Discovery Services, Lippy led therapeutic antibody discovery projects at Pfizer, Igenica, Ablexis and Lake Pharma. Lippy received his PhD from Harvard University and did postdoctoral research at the Genomics Institute of the Novartis Research Foundation in San Diego.

Agenda Sessions

  • Engineering Human Antibodies Discovered with AlivaMab® Mouse into a Bispecific Antibody Therapeutic


Speakers at this event